Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FACT: Folic Acid for Preeclampsia Prevention
NCT01355159Phase 3Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Apr 2011
- Primary completion
- Jul 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 5
01
Overview
A Phase 3 trial of folic acid in preeclampsia, sponsored by Ottawa Hospital Research Institute. Started Apr 2011; status: completed.
02
Drugs
folic acid
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT01355159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01355159.